Stock listing

Therapeuticsmd, Inc.

Selected listing: 29TA · DUS · EUR · DE

Therapeuticsmd, Inc. (Dusseldorf:29TA), Health Technology. Latest release Aug 11, 2026: TherapeuticsMD Announces Second Quarter 2026 Financial Results.

29TA:DUSEURDEUpdated October 2, 2026

Ticker: Dusseldorf:29TA
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Dusseldorf
Currency: EUR

About Therapeuticsmd, Inc.

TherapeuticsMD, Inc. (Ticker: TXMD) is a public company based in the United States, focusing on women's health.

Latest news from Therapeuticsmd, Inc.

TherapeuticsMD Announces Second Quarter 2026 Financial Results

August 11, 2026

TherapeuticsMD Announces First Quarter 2026 Financial Results

May 12, 2026

TherapeuticsMD : Amendment to Annual Report (Form 10-K/A)

April 1, 2026

TherapeuticsMD Announces Full Year 2025 Financial Results

March 30, 2026

TherapeuticsMD Announces Third Quarter 2025 Financial Results

November 12, 2025

All Therapeuticsmd, Inc. news →

Events

Replays

TherapeuticsMD, Inc. (TXMD) Q2 2022 Earnings Call
Mon, Aug 15, 2022 · 08:30 AM ET
Watch
TherapeuticsMD, Inc. (TXMD) Q1 2022 Earnings Call
Mon, May 16, 2022 · 04:30 PM ET
Watch
TherapeuticsMD, Inc. (TXMD) Q4 2021 Earnings Call
Thu, Mar 10, 2022 · 08:30 AM ET
Watch

Research Therapeuticsmd, Inc.

Therapeuticsmd, Inc. company profile

View the public company page for Therapeuticsmd, Inc. on 6ix.

Therapeuticsmd, Inc. news

Read company news and market updates connected to Therapeuticsmd, Inc..

Therapeuticsmd, Inc. investor events

Find investor webinars, events, and replay context for Therapeuticsmd, Inc..